IP Library Granted Patent US 11,786,731
Granted Patent B2
US 11,786,731 · App. 17/748,873 · Granted Oct 17, 2023

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

Inventors: Konstantinos Alataris (Belmont, CA); Andre B. Walker (Monte Sereno, CA); Jon Parker (San Jose, CA); Yougandh Chitre (Santa Clara, CA); Sangsoo Wesley Park (San Jose, CA); James R. Thacker (Homer, AK)
Assignee: Nevro Corp.
A61N1/36071A61N1/0551A61N1/0553A61N1/06A61N1/323A61N1/3616A61N1/36021A61N1/36062A61N1/36089A61N1/36128A61N1/36132A61N1/36157A61N1/36164A61N1/36167A61N1/36171A61N1/36175A61N1/36178A61N1/36182A61N1/3787A61N1/37235A61N1/37241A61N1/37247A61N1/37264G01R21/133A61N1/3605
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,786,731
App. No.
17/748,873
Granted
Oct 17, 2023
Kind
B2
Abstract

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region to address low back pain without creating unwanted sensory and/or motor side affects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims (22)

1. A method of treating a patient having pain, comprising:

programming a signal generator to repeatedly (a) deliver a non-paresthesia producing electrical signal to the patient's spinal cord via at least one implanted signal delivery element for a first period, and (b) halt delivery of the non-paresthesia producing electrical signal for a second period of between one hour and one day,

wherein the second period has a duration that accounts for a duration between initiating delivery of the non-paresthesia producing electrical signal and an onset of the pain relief, such that pain relief occurs during both the first and second periods.

2. The method of claim 1 wherein the signal generator is an implantable signal generator.

3. The method of claim 2 wherein the implantable signal generator includes a battery; and wherein the battery is a non-rechargeable battery.

4. The method of claim 1 wherein the signal generator is an external signal generator.

5. The method of claim 1 wherein the signal generator has reduced power consumption by virtue of halting delivery of the non-paresthesia producing electrical signal for the second period.

6. A method of treating a patient having pain, comprising:

programming a signal generator to repeatedly (a) deliver a non-paresthesia producing electrical signal to the patient's spinal cord via at least one implanted signal delivery element for a first period, and (b) halt delivery of the non-paresthesia producing electrical signal for a second period of between one hour and one day,

wherein the second period has a total duration that accounts for a first duration over which pain relief persists after delivery of the non-paresthesia production electrical signal is halted, and (b) a second duration between initiating delivery of the non-paresthesia producing electrical signal and an onset of the pain relief, such that pain relief occurs during both the first and second periods.

7. The method of claim 6 wherein the signal generator is an implantable signal generator.

8. The method of claim 7 wherein the implantable signal generator includes a battery, and wherein the battery is a non-rechargeable battery.

9. The method of claim 6 wherein the signal generator is an external signal generator.

10. The method of claim 6 wherein the signal generator has reduced power consumption by virtue of halting delivery of the non-paresthesia producing electrical signal for the second period.

11. The method of claim 6 wherein the non-paresthesia producing electrical signal has a pulse width in a pulse width range of from about 10 microseconds to about 333 microseconds and an amplitude in an amplitude range of from about 0.5 mA to about 10 mA.

12. A method of treating a patient having pain, comprising:

programming a signal generator to repeatedly (a) deliver a non-paresthesia producing electrical signal to the patient's spinal cord via at least one implanted signal delivery element for a first period, wherein the non-paresthesia-producing electrical signal has sequential bi-phasic pulses with a pulse width in a pulse width range of from 10 microseconds to 333 microseconds; and (b) halt delivery of the non-paresthesia producing electrical signal for a second period of between one hour and one day,

wherein an effect of the non-paresthesia producing electrical signal is to reduce patient pain without causing paresthesia, during both the first and second periods.

13. The method of claim 12 wherein the signal generator is an implantable signal generator.

14. The method of claim 13 wherein the implantable signal generator includes a battery, and wherein the battery is a non-rechargeable battery.

15. The method of Tim 173 wherein the signal generator is an external signal generator.

16. The method of claim 12 wherein the signal generator has reduced power consumption by virtue of halting delivery of the non-paresthesia producing electrical signal for the second period.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2022
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 060052/0294 →
Continuity (7)
Continuation 16537443 · Aug 9, 2019
Continuation 14522500 · Oct 23, 2014
Continuation 14164100 · Jan 24, 2014
Continuation 12765747 · Apr 22, 2010
Provisional Application 61176868 · May 8, 2009
Provisional Application 61171790 · Apr 22, 2009
Related Publication 20220273950A1 · Sep 1, 2022
Cited By (1)
US 12,465,776